Prostate Cancer
Men's Attitudes Towards Participation in Organised Prostate Cancer Testing: An Abductive Thematic Analysis.
January 22, 2025
Impact of Genomic Classifiers on Risk Stratification and Treatment Intensity in Patients With Localized Prostate Cancer : A Systematic Review.
January 22, 2025
Cancer-specific mortality after radical prostatectomy versus radiotherapy in incidental prostate cancer.
January 22, 2025
« Augmented radiotherapy » in the management of high-risk prostate cancer (PCa): a systematic review.
January 22, 2025
Low baseline IsoPSA Index is associated with a Prolonged Low Risk of Clinically Significant Prostate Cancer Diagnosis in Men with an Elevated PSA.
January 21, 2025
Personalized Dynamic Prediction Model for Biopsy Timing in Patients With Prostate Cancer During Active Surveillance.
January 21, 2025
Biochemical failure-free survival of 18F-rhPSMA-7 and 18F-flotufolastat PET-guided salvage radiotherapy for patients with recurrent prostate cancer.
January 21, 2025
Impact of Additional Active Treatment for Prostate Cancer on Health-related Quality of Life of Men: Results from the EUPROMS 2.0 1-year Follow-up Survey.
January 20, 2025
Prospective validation study of a combined urine and plasma test for predicting high-grade prostate cancer in biopsy naïve men.
January 20, 2025
Current insights on PSMA PET/CT in intermediate-risk prostate cancer: a literature review.
January 20, 2025
Evaluating the feasibility of AI-predicted bpMRI image features for predicting prostate cancer aggressiveness: a multi-center study.
January 20, 2025
Racial Differences in Survival and Healthcare Resource Utilization Among Medicaid-Insured Adults With Metastatic Prostate Cancer.
January 17, 2025
Hematospermia does not increase the risk of prostate cancer detection in prostate biopsy.
January 17, 2025